Potential molecular targets of statins in the prevention of hepatocarcinogenesis
Introduction and alm. Hepatocellular carcinoma (HCC) represents 90% of liver tumors. Statins, may reduce the incidence of various tumors, including HCC. Antitumoral activities may be mediated by changes in transforming growth factor-beta (TGF-βΙ) and thyroid hormones (TH) regulation. Aim. The aim of...
Main Authors: | Ezequiel Ridruejo, Giselle Romero-Caími, María J. Obregón, Diana Kleiman de Pisarev, Laura Alvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-05-01
|
Series: | Annals of Hepatology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119302054 |
Similar Items
-
Behavior of three hypocholesterolemic peptides from soy protein in an intestinal model based on differentiated Caco-2 cell
by: Gilda Aiello, et al.
Published: (2018-06-01) -
Regulatory Effects of Statins on SIRT1 and Other Sirtuins in Cardiovascular Diseases
by: Danial Khayatan, et al.
Published: (2022-05-01) -
The role of statins in clinical medicine -LDL - cholesterol lowering and beyond
by: Swiss Medical Weekly
Published: (2006-01-01) -
Advances in ovarian cancer treatment using a combination of statins with other drugs
by: Lei Xia, et al.
Published: (2023-01-01) -
Statin Autoimmune Necrotizing Myopathy Diagnosed After a Motor Vehicle Accident
by: Julia Poe, et al.
Published: (2019-01-01)